Eisai Inc. announced on June 22nd, 2015, that the U.S. Food and Drug Administration (FDA) has approved FYCOMPA® (perampanel) CIII for adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in patients age 12 and older. FYCOMPA, the...
Thursday, April 24, 2014 8:00 am – 4:00 pm South Lawn, State Capitol Sacramento, California Walk through a GIANT Brain Exhibit! “Love Your Brain Now” Epilepsy Resources for policymakers and state agencies Student tools reaching every school district in California...
